Burning Rock Biotech Limited growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: -1.7%
EBITDA: +87.0%
EBIT: +76.3%
EPS: +75.6%
Free cash flow: +51.3%
Operating cash flow: +54.7%

Forward estimates

Revenue: —
EBITDA: —
EPS: —

Three-year CAGR

Revenue: -1.4%
EBITDA: +88.2%
EBIT: +84.7%
Net income: +84.0%
EPS: -47.3%
Free cash flow: +65.7%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.